Back to 
BAKER BROS. ADVISORS LPCMCMTA
BAKER BROS. ADVISORS LPCMCMTA2 quarters
Position history for BAKER BROS. ADVISORS LP's holdings in Clementia Pharmaceuticals Inc.
No. Baker Bros. Advisors exited its CMTA (Clementia Pharmaceuticals) position in Q2 2019. Its Q1 2019 13F listed 3,724,445 shares worth $97.2M. Baker Bros. Advisors already held CMTA in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$97.2M
Total Shares Change
-3.7M
Quarter-by-Quarter History
Other major holders of CMTA: Alyeska Investment Group, L.P., TUDOR INVESTMENT CORP ET AL, DRIEHAUS CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC., MILLENNIUM MANAGEMENT LLC